Concerns Over AstraZeneca Data

AstraZeneca PLC said it would update and reissue later this week efficacy data from human trials of its Covid-19 vaccine after U.S. officials took the rare move of publicly questioning their accuracy—the latest misstep by […]

By |2021-03-24T10:51:10-04:00March 24, 2021|Articles|Comments Off on Concerns Over AstraZeneca Data

U.K. Authorizes COVID-19 Vaccine

The U.K. became the first Western nation to grant emergency-use authorization for a Covid-19 vaccine, clearing a shot developed by Pfizer Inc. of the U.S. and BioNTech SE of Germany to be distributed in limited […]

By |2020-12-03T11:02:24-05:00December 3, 2020|Articles|Comments Off on U.K. Authorizes COVID-19 Vaccine

Pfizer Shows Positive Vaccine Data

The drug maker Pfizer announced on Monday that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19, a promising development as the world has waited anxiously for […]

By |2020-11-10T12:14:31-05:00November 10, 2020|Articles|Comments Off on Pfizer Shows Positive Vaccine Data

AstraZeneca Strikes Vaccine Deal

AstraZeneca reached a licensing deal with Chinese firm BioKangtai to help provide its adenovirus vector-based COVID-19 vaccine candidate, created by the University of Oxford, to China, AstraZeneca said in a social media post on Thursday. The pair will […]

By |2020-08-07T11:46:19-04:00August 7, 2020|Articles|Comments Off on AstraZeneca Strikes Vaccine Deal

Moderna Gets $483 Million in Funding

Moderna Inc. said Thursday it reached an agreement to receive as much as $483 million in funding from a federal agency to accelerate the development and production of its closely watched experimental vaccine against the new Coronavirus...

By |2020-04-17T10:35:45-04:00April 17, 2020|Articles|Comments Off on Moderna Gets $483 Million in Funding